A longitudinal study of risk factors for incident drug use in adults: Findings from a representative sample of the US population

Canadian Journal of Psychiatry

Volumn 56, Issue 11, 2011, Pages 686-695

  Harrington, Michael ^a   Robinson, Jennifer ^a   Bolton, Shay Lee ^a   Sareen, Jitender ^a   Bolton, James M ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Epidemiology; Incident drug use; National epidemiologic survey on alcohol and related conditions; NESARC

Indexed keywords

AMPHETAMINE; CANNABIS; COCAINE; DIAMORPHINE; ILLICIT DRUG; OPIATE; PSYCHEDELIC AGENT; SEDATIVE AGENT; TRANQUILIZER;

ABSTINENCE; ADULT; AGED; ALCOHOL ABUSE; ALCOHOLISM; ANXIETY DISORDER; ARTICLE; CANNABIS SMOKING; CHILD ABUSE; CHILD NEGLECT; CHILDHOOD; CONTROLLED STUDY; DEMOGRAPHY; DRUG ABUSE PATTERN; DRUG DEPENDENCE; DRUG MISUSE; EDUCATIONAL STATUS; ETHNICITY; FAMILY HISTORY; FAMILY VIOLENCE; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; INCIDENT DRUG USE; INHALANT ABUSE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MEDICAL HISTORY; MENTAL DISEASE; MOOD DISORDER; PERSONALITY DISORDER; POSTTRAUMATIC STRESS DISORDER; PRESCRIPTION; PSYCHOTRAUMA; RISK FACTOR; SEXUAL CRIME; SOCIAL STATUS; TOBACCO DEPENDENCE; UNITED STATES; VIOLENCE;

EID: 81855211794     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674371105601107     Document Type: Article

References (79)

1. Rehm J, Gnam W, Popova S, et al. The costs of alcohol, illegal drugs, and tobacco in Canada, 2002. J Stud Alcohol Drugs. 2007;68:886-895. (Pubitemid 350144498)
2. World Health Organization. The global burden of disease: 2004 update [Internet]. Geneva (CH): WHO; 2008 [cited 2011 Mar]. Available from: http://www.who.int/entity/healthinfo/global-burden-disease/GBD-report- 2004update-full.pdf.
3. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8-19. (Pubitemid 24028993)
4. Compton WM, Thomas YF, Stinson FS, et al. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the National Epidemiological Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2007;64:566-576. (Pubitemid 46718289)
5. Ridenour TA, Cottler LB, Compton WM, et al. Is there a progression from abuse disorders to dependence disorders? Addiction. 2003;98:635-644. (Pubitemid 36638202)
6. Fergusson DM, Boden JM. Cannabis use and later life outcomes. Addiction. 2008;103:969-976. (Pubitemid 351703484)
7. Greene SL, Kerr F, Braitberg G. Review article: amphetamines and related drugs of abuse. Emerg Med Australas. 2008;20:391-402.
8. Kelly E, Darke S, Ross J. A review of drug use and driving: epidemiology, impairment, risk factors and risk perceptions. Drug Alcohol Rev. 2004;23:319-344. (Pubitemid 39305501)
9. van Laar M, van Dorsselaer S, Monshouwer K, et al. Does cannabis use predict the first incidence of mood and anxiety disorders in the adult population? Addiction. 2007;102:1251-1260. (Pubitemid 47037929)
10. Hayatbakhsh MR, Najman JM, Jamrozik K, et al. Cannabis and anxiety and depression in young adults: a large prospective study. J Am Acad Child Adolesc Psychiatry. 2007;46:408-417.
11. Moore TH, Zammit S, Lingford-Hughes A, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 2007;370:319-328. (Pubitemid 47094993)
12. Garlow SJ, Purselle DC, Heninger M. Cocaine and alcohol use preceding suicide in African American and white adolescents. J Psychiatr Res. 2007;41:530-536. (Pubitemid 46227439)
13. Bijl RV, DeGraaf R, Ravelli A, et al. Gender and age-specific first incidence of DSM-III-R psychiatric disorders in the general population: results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol. 2002;37:372-379. (Pubitemid 36097274)
14. de Graaf R, Bijl RV, Smit F, et al. Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: findings from the Netherlands Mental Health Survey and Incidence Study. Am J Psychiatry. 2002;159:620-629. (Pubitemid 34274945)
15. Grant BF, Goldstein RB, Chou SP, et al. Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Mol Psychiatry. 2009;14:1051-1066.
16. Chen CY, Lin KM. Health consequences of illegal drug use. Curr Opin Psychiatry. 2009;22:287-292.
17. Hyman SM, Garcia M, Kemp K, et al. A gender specific psychometric analysis of the early trauma inventory short form in cocaine dependent adults. Addict Behav. 2005;30:847-852. (Pubitemid 40516849)
18. MacMillan HL, Fleming JE, Streiner DL, et al. Childhood abuse and lifetime psychopathology in a community sample. Am J Psychiatry. 2001;158:1878-1883. (Pubitemid 33054782)
19. Simpson TL, Miller WR. Concomitance between childhood sexual and physical abuse and substance use problems. A review. Clin Psychol Rev. 2002;22:27-77. (Pubitemid 33109012)
20. Compton WM, Conway KP Stinson FS, et al. Changes in the prevalence of major depression and comorbid substance use disorders in the United States between 1991-1992 and 2001-2002. Am J Psychiatry. 2006;163:2141-2147. (Pubitemid 46114235)
21. Conway KP, Compton W, Stinson FS, et al. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2006;67:247-257. (Pubitemid 43357471)
22. Hasin DS, Stinson FS, Ogburn E, et al. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2007;64:830-842. (Pubitemid 47026379)
23. Kessler RC, Nelson CB, McGonagle KA, et al. The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am J Orthopsychiatry. 1996;66:17-31. (Pubitemid 26031236)
24. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990;264:2511-2518.
25. Rohde P, Lewinsohn PM, Seeley JR. Psychiatric comorbidity with problematic alcohol use in high school students. J Am Acad Child Adolesc Psychiatry. 1996;35:101-109. (Pubitemid 26011138)
26. Hamil-Luker J, Land KC, Blau, J. Diverse trajectories of cocaine use through early adulthood among rebellious and socially conforming youth. Soc Sci Res. 2004;33:300-321. (Pubitemid 38670624)
27. Volkow N, Li TK. The neuroscience of addiction. Nat Neurosci. 2005;8:1429-1430. (Pubitemid 41573649)
28. Brody GH, Beach SR, Philibert RA, et al. Parenting moderates a genetic vulnerability factor in longitudinal increases in youths'substance use. J Consult Clin Psychol. 2009;77:1-11.
29. Dickerson DL, O'Malley SS, Canive J, et al. Nicotine dependence and psychiatric and substance use comorbidities in a sample of American Indian male veterans. Drug Alcohol Depend. 2009;99:169-175.
30. Sintov ND, Kendler KS, Walsh D, et al. Predictors of illicit substance dependence among individuals with alcohol dependence. J Stud Alcohol Drugs. 2009;70:269-278.
31. Valdez A, Neaigus A, Cepeda A. Potential risk factors for injecting among Mexican American non-injecting heroin users. J Ethn Subst Abuse. 2005;6:49-73.
32. van den Bree MB, Pickworth WB. Risk factors predicting changes in marijuana involvement in teenagers. Arch Gen Psychiatry. 1005;62:311-319.
33. Hser YI, Huang D, Chou CP, et al. Trajectories of heroin addiction: growth mixture modeling results based on a 33-year follow-up study. Eval Rev. 2007;31:548-563.
34. O'Brien MS, Anthony JC. Risk of becoming cocaine dependent: epidemiological estimates for the United States 2000-2001. Neuropsychopharmacology. 2005;30:1006-1018. (Pubitemid 40570915)
35. Perkonigg A, Goodwin RD, Fiedler A, et al. The natural course of cannabis use, abuse and dependence during the first decades of life. Addiction. 2008;103:439-449. (Pubitemid 351208093)
36. Grant BF, Harford TC, Muthen BO, et al. DSM-IV alcohol dependence and abuse: further evidence of validity in the general population. Drug Alcohol Depend. 2007;86:154-166. (Pubitemid 44830094)
37. Grant BF, Hasin DS, Stinson FS, et al. Prevalence, correlates, and disability of personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2004;65:948-958.
38. Grant BF, Chou SP, Goldstein RB, et al. Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2008;69:533-545. (Pubitemid 351792327)
39. Bolton JR, Belik SL, Enns MW, et al. Exploring the correlates of suicide attempts among individuals with major depressive disorder: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2008;69:1139-1149. (Pubitemid 352031598)
40. Grant BF, Dawson DA, Stinson FS, et al. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug Alcohol Depend. 2003;71:7-16. (Pubitemid 36734856)
41. Ruan WJ, Goldstein RB, Chou SP, et al. The alcohol use disorder and associated disabilities interview schedule-IV (AUDADIS-IV): reliability of new psychiatric diagnostic modules and risk factors in a general population sample. Drug Alcohol Depend. 2008;92:27-36. (Pubitemid 350218195)
42. Kessler RC, Crum RM, Warner LA, et al. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry. 1997;54:313-321. (Pubitemid 27171916)
43. Research Triangle Institute. Software for survey data analysis (SUDAAN), Version 8.0. Research Triangle Park (NC): Research Triangle Institute; 2002.
44. Hawkins DJ, Hill KG, Guo J, et al. Substance use norms and transitions in substance use: implications for the gateway hypothesis. In: Kandel, editor. Stages and pathways of drug involvement: examining the gateway hypothesis. Cambridge (MA): Cambridge University Press; 2002. p 42-64.
45. Sanchez-Samper X, Knight JR. Drug abuse by adolescents: general considerations. Pediatr Rev. 2009;30:83-92.
46. Krillova GP, Vanyukov MM, Kirisci L, et al. Physical maturation, peer environment, and the ontogenesis of substance use disorders. Psychiatry Res. 2008;28:43-53.
47. Miller P. Family structure, personality, drinking, smoking and illicit drug use: a study of UK teenagers. Drug Alcohol Depend. 1997;14:121-129. (Pubitemid 27246413)
48. Mulder RT. Alcoholism and personality. Aust N Z J Psychiatry. 2002;36:44-52. (Pubitemid 34284997)
49. Duran B, Oetzel J, Parker J, et al. Intimate partner violence and alcohol, drug, and mental disorders among American Indian women in primary care. Am Indian Alsk Native Ment Health Res. 2009;16:11-27.
50. Hequembourg A, Mancuso R, Miller B. A comparative study examining associations between women's drug-related lifestyle factors and victimization within the family. Violence Vict. 2006;21:231-246. (Pubitemid 43668268)
51. Brewer DD, Fleming CB, Haggerty KP. Past and future research on the crack cocaine-domestic violence link. Am J Public Health. 2005;95:1493; author reply 1493-1494.
52. Flake DF. Individual, family, and community risk markers for domestic violence in Peru. Violence Against Women. 2005;11:353-373. (Pubitemid 40305915)
53. Pears K, Capaldi DM, Owen LD. Substance use risk across three generations: the roles of parent discipline practices and inhibitory control. Psychol Addict Behav. 2007;21:373-386. (Pubitemid 47488764)
54. Prescott CA, Sullivan PF, Kuo PH, et al. Genomewide linkage study in the Irish affected sib pair study of alcohol dependence: evidence for a susceptibility region for symptoms of alcohol dependence on chromosome 4. Mol Psychiatry. 2006;11:603-611.
55. Agrawal A, Lynskey MT. The genetic epidemiology of cannabis use, abuse and dependence. Addiction. 2006;101:801-812. (Pubitemid 43727514)
56. Bolton JM, Robinson J, Sareen J. Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on Alcohol and Related Conditions. J Affect Disord. 2009;115:367-375.
57. Weiss RD, Griffin ML, Mirin SM. Drug abuse as self-medication for depression: an empirical study. Am J Drug Alcohol Abuse. 1992;18:121-129.
58. De Bernardo GL, Newcomb M, Toth A, et al. Comorbid psychiatric and alcohol abuse/dependence disorders: psychosocial stress, abuse, and personal history factors of those in treatment. J Addict Dis. 2002;21:43-59. (Pubitemid 35205002)
59. Herrero MJ, Domingo-Salvany A, Torrens M, et al. Personality profile in young current regular users of cocaine. Subst Use Misuse. 2008;43:1378-1394.
60. Karterud S, Arefjord N, Andresen NE, et al. Substance use disorders among personality disordered patients admitted for day hospital treatment. Implications for service developments. Nord J Psychiatry. 2009;63:57-63.
61. Scheier LM, Newcomb MD. Differentiation of early adolescent predictors of drug use versus abuse: a developmental risk-factor model. J Subst Abuse. 1991;3:277-299.
62. Robinson J, Sareen J, Cox BJ, et al. Self-medication of anxiety disorders with alcohol and drugs: results from a nationally representative sample. J Anxiety Disord. 2009;23:38-45.
63. Bolton J, Cox B, Clara I, et al. Use of alcohol and drugs to self-medicate anxiety disorders in a nationally representative sample. J Nerv Ment Dis. 2006;194:818-825. (Pubitemid 44747902)
64. de Beaurepaire R, Lukasiewicz M, Beauverie P, et al. Comparison of self-reports and biological measures for alcohol, tobacco, and illicit drugs consumption in psychiatric inpatients. Eur Psychiatry. 2007;22:540-548. (Pubitemid 350087648)
65. Benowitz NL. Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annu Rev Pharmacol Toxicol. 2009;49:57-71.
66. Brigham GS, Schroeder G, Schindler E. Addressing smoking in community drug abuse treatment programs: practical and policy considerations. J Psychoactive Drugs. 2007;39:435-441. (Pubitemid 351412313)
67. O'Hare T. Mental health problems and alcohol abuse: co-occurrence and gender differences. Health Soc Work. 1995;20:207-214.
68. Cadoni C, Pisanu A, Solinas M, et al. Behavioural sensitization after repeated exposure to Delta 9-tetrahydrocannabinol and cross-sensitization with morphine. Psychopharmacology (Berl). 2001;158:259-266. (Pubitemid 33071163)
69. Smith RF. Animal models of periadolescent substance abuse. Neurotoxicol Teratol. 2003;25:291-301. (Pubitemid 36579180)
70. Cleveland HH, Wiebe RP. Understanding the association between adolescent marijuana use and later serious drug use: gateway effect or developmental trajectory? Dev Psychopathol. 2008;20:615-632. (Pubitemid 351584027)
71. Galaif ER, Newcomb MD. Predictors of polydrug use among four ethnic groups: a 12-year longitudinal study. Addict Behav. 1999;24:607-631. (Pubitemid 29417981)
72. Lessem JM, Hopfer CJ, Haberstick BC, et al. Relationship between adolescent marijuana use and young adult illicit drug use. Behav Genet. 2006;36:498-506. (Pubitemid 43967646)
73. Degenhardt L, Chiu WT, Conway K, et al. Does the 'gateway'matter? Associations between the order of drug use initiation and the development of drug dependence in the National Comorbidity Study Replication. Psychol Med. 2009;39:157-167.
74. Fergusson DM, Boden JM, Horwood LJ. Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis. Addiction. 2006;101:556-569. (Pubitemid 43375619)
75. Degenhardt L, Dieker L, Chiu WT, et al. Evaluating the drug use "gateway" theory using cross-national data: consistency and associations of the order of initiation of drug use among participants in the WHO World Mental Health Surveys. Drug Alcohol Depend. 2010;108:84-97.
76. Morral A, McCaffrey D, Paddock S. Reassessing the marijuana gateway effect. Addiction. 2002;97:1493-1504. (Pubitemid 36009101)
77. Compton W, Thomas Y, Stinson F, et al. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States. Arch Gen Psychiatry. 2007;64:566-576.
78. Flovig J, Vaaler A, Morken G. Substance use at admission to an acute psychiatric department. Nord J Psychiatry. 2009;63:113-119.
79. Wustoff L, Waal H, Ruud T, et al. A cross-sectional study of patients with and without substance use disorders in community mental health centres. BMC Psychiatry. 2011;11:93.